Current stock page

Stock Analysis

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis

Tandem Diabetes Care, Inc. (TNDM) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

TNDM Stock Analysis Summary

Tandem Diabetes Care, Inc. (TNDM) currently has an AIQ Score of 55/100, indicating a neutral setup. Value is the strongest factor at 64/100. Risk is the weakest current factor at 38/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data

TNDM at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$17.05
AIQ Score55/100
Overall ViewNeutral
Technical Analysis ConsensusStrong Buy
Market Cap$1.4B
P/E Ratio (TTM)-23.74
Forward P/E—
EPS (Q3 FY2026)-$0.10
Revenue (Q3 FY2026)$283.69M
Dividend Yield (TTM)0.00%
Beta1.07
Volume2.35M
52-week range$12.26-$29.65
RSI 1459.69
50-Day SMA$17.40
200-Day SMA$18.84
Analyst Price Target$19.00
Next EarningsFeb 18, 2027
As of Nov 18, 2026 · Market close

TNDMTandem Diabetes Care, Inc.

Healthcare / Medical - Devices

Low Priority

In Line With Peers

NeutralEdge 5/10
$17.05−$0.01 (−0.06%)

Latest quote

  • Momentum
    59
  • Value
    64
  • Quality
    51
  • Risk resilience
    38
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

TNDM Stock Analysis Summary

Tandem Diabetes Care, Inc. (TNDM) currently has an AIQ Score of 55/100, indicating a neutral setup. Value is the strongest factor at 64/100. Risk resilience is the weakest current factor at 38/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data
AIQ Composite Posture: Neutral

In a neutral regime, TNDM has AIQ Score of 55/100 with Value base of 64/100 and fading Risk resilience at 38/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Value (64/100) leads while Risk resilience (38/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · -0.06% stock move · TNDM classified in Medical - Devices.

Current Evidence

NeutralTNDM is in a neutral AIQ regime; Value is the strongest visible factor at 64/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is TNDM Bullish or Bearish Right Now?

TNDM currently has a neutral overall setup. Value is the strongest factor at 64/100, while Risk Resilience is weakest at 38/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Price is +15.35% above its 50-day SMA.
  • - Analyst target implies +11.44% upside from the latest quote.
  • - Technical consensus has more buy votes than sell votes (38 vs 3).
Bear Case
  • - Risk Resilience is weak at 38/100.

Current Consensus

TNDM's Technical Analysis Consensus is currently Strong Buy, with 38 buy, 5 neutral, and 3 sell votes. TNDM's 14-day RSI is 59.69, which places the stock in a constructive momentum range. TNDM's beta is 1.07, indicating market sensitivity broadly in line with the market.

Signal Confidence
High agreement

What Changed in TNDM?

The largest recent change in TNDM is Momentum moving down by 2.0 points over the available 7-day comparison window. Value remains the strongest visible factor.

AIQ Score
+0.0
Momentum
-2.0
Quality
+0.0
Risk
-1.0

What Would Change the TNDM Outlook?

The current neutral outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

TNDM Decision Framework

Public evidence layers, setup checks, and risk context for Tandem Diabetes Care, Inc..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis

Tandem Diabetes Care, Inc. has an AIQ Score of 55/100 in a Neutral regime. Value is strongest at 64/100. Beta is 1.07, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextTNDM is in a Neutral AIQ regime with score 55/100.
Signal ConflictThe primary conflict is that value leads at 64/100 while risk lags at 38/100.
Factor EvidenceMomentum 59/100 · Value 64/100 · Quality 51/100 · Risk 38/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthWait

Value is the strongest factor at 64/100.

TimingWait

Momentum is 59/100 and RSI (14) is 59.7.

Regime fitWait

TNDM is in a Neutral regime at 55/100.

Risk controlFail

Risk factor is 38/100 with beta 1.07 and annual volatility 75.74%.

ConflictWait

Current conflict: value leads at 64/100 while risk lags at 38/100.

AIQ Score
55/100
Price
$17.05
Beta
1.07
RSI (14)
59.7

TNDM Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

TNDM Fundamentals

TNDM valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$283.69M
Net income
-$7.09M
Free cash flow
-$5.51M
View full TNDM fundamental analysis

TNDM Technical Analysis

TNDM technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Buy
RSI 14
59.69
Price vs SMA-50
+15.35%
View full TNDM technical analysis

TNDM Stock Catalysts

Track TNDM earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Feb 18, 2027
Analyst target
$19.00
News items
5
View TNDM earnings and stock catalysts

TNDM Dividend Analysis

TNDM dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View TNDM dividend history and analysis

TNDM Financial Data

TNDM revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$283.69M
EPS
-$0.10
Periods
8
View TNDM financials

TNDM Risk Analysis

TNDM volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.07
Risk score
38/100
1Y volatility
75.74%
View TNDM risk analysis

TNDM Stock News

TNDM stock news, market tone, recent headlines, and catalyst context.

News items
5
Updated
Nov 18, 2026
Sentiment
—
Read TNDM stock news

TNDM vs Medical - Devices Peers

Current peer cohort: TNDM · UFPT · ATEC · AXGN · BBNX. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
TNDM
Current stock
55/10064/10059/10038/1000.4975.74%Current
UFPT
UFP Technologies, Inc.
68/10061/10081/10056/1000.6950.83%TNDM vs UFPT
ATEC
Alphatec Holdings, Inc.
48/10061/10047/10028/100-0.9478.93%TNDM vs ATEC
AXGN
AxoGen, Inc.
65/10033/10082/10055/1001.6161.27%TNDM vs AXGN
BBNX
Beta Bionics, Inc.
54/10039/10072/10036/100-0.1684.66%TNDM vs BBNX
Pairwise Compare links: UFPT · ATEC · AXGN · BBNXTNDM vs UFPTTNDM vs ATECTNDM vs AXGNTNDM vs BBNXCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 18, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a TNDM stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for TNDM: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 19, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-23.74
As of Nov 18, 2026
Revenue growth
13.82%
Gross margin
56.65%
Current debt / equity
5.45
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$283.69M
Quarter net income
-$7.09M
Quarter free cash flow
-$5.51M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bearish
Momentum
Bullish
RSI 14
59.69
MACD
0.37

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
38/100
Beta
1.07
Annual volatility
75.74%
Max drawdown
-54.64%

TNDM Stock FAQ

What is TNDM stock price today?

Tandem Diabetes Care, Inc.'s current stock price is $17.05. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is TNDM bullish or bearish right now?

TNDM's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is TNDM's market cap?

TNDM's market cap is $1.4B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is TNDM's current P/E ratio?

TNDM's current P/E ratio is -23.74 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is TNDM's RSI?

TNDM's 14-day RSI is 59.69 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is TNDM above its 50-day and 200-day moving averages?

TNDM is 15.35% from its 50-day SMA and 6.54% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is TNDM's next earnings date?

TNDM's next earnings date is currently listed as Feb 18, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does TNDM pay a dividend?

TNDM's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.